This inventor holds 1 USPTO granted patent. Top assignee: Hahnemann University. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Innovations in Hematopoietic Cell Research by Doris A. Morgan
Introduction
Doris A. Morgan is a notable inventor based in Voorhees, NJ (US). She has made significant contributions to the field of hematopoietic cell research. Her work focuses on the development of cell lines that can aid in the understanding and treatment of leukemia.
Latest Patents
Doris A. Morgan holds a patent for a factor-dependent hematopoietic cell line known as HU-01. This innovative cell line provides the first in vitro system in which human CD34 positive hematopoietic cells have been induced to undergo complete differentiation into enucleated hemoglobin-containing erythrocytes. The HU-01 cells may serve as a source of monoclonal antibodies that are useful for early diagnosis and potential treatment of human leukemia conditions. Additionally, these cells may produce regulatory factors with therapeutic utility.
Career Highlights
Doris A. Morgan is affiliated with Hahnemann University, where she has been instrumental in advancing research in hematopoietic cells. Her work has garnered attention for its potential applications in medical science, particularly in the treatment of blood-related disorders.
Conclusion
Doris A. Morgan's contributions to hematopoietic cell research exemplify the impact of innovative thinking in the medical field. Her patent and ongoing research continue to pave the way for advancements in leukemia treatment and diagnosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile